核心观点 USDA3 月棉花报告维持 25/26 年国棉与美棉需求缺口判断。本周 USDA3 月棉花报告更新，2025 年美国 GDP 增长 2.2%， 居民消费支出的增加成为核心驱动力之一，反映在终端市场上，美国服装零售店销售额增长 5%，创历史新高。而同 时美国棉制品进口量并未同步增长，全年维持在 330 万吨的水平，表明零售商为应对波动的关税环境、降低运营成 本，主动选择削减库存。与此同时，美国棉制品进口的供应国结构发生显著变化：印度凭借垂直整合的纺织供应链 优势，首次取代中国成为美国最大的棉制品供应国。而中国供应份额的下滑，主要受地缘政治风险加剧以及美国对 华出台的 10-125%高额关税影响，越南、孟加拉国、巴基斯坦等其他棉花供应国也扩大了在美国的市场份额。 细分行业景气指标：运动户外（稳健向上）、男装（底部企稳）、女装（底部企稳）、家纺（拐点向上）、中游代 工（稳健向上）、纺织原材料（拐点向上）、美护（稳健向上）、医美（稳健向上）。 投资建议 1）弹性方向：海澜之家顺应消费降级趋势商业转型拓展创新市区奥莱业态，未来开店空间较大且具备较强盈利能力， 同时主业成人装筑底恢复，分红水平近年维持在高位，滔 ...

2026.03. 12 本文字数：1377，阅读时长大约2分钟 作者 | 第一财经 刘晓颖 2026年3月11日晚间，逸仙电商（NYSE:YSG）于盘前发布公告，宣布完成1.2亿美元战略融资，由创始人黄锦峰与信宸资本共同领投。 "本次增持代表了我对逸仙电商长期价值的坚定信念，也彰显了我们推进全球化战略的决心。"逸仙电商创始人、董事长兼首席执行官黄锦峰表示，未 来将依托信宸资本的资源优势，加强全球供应链整合与海外市场渗透，通过战略并购吸纳全球优质美妆资源。 中信资本董事长兼首席执行官、信宸资本董事长张懿宸则表示，看好逸仙电商的国际化视野与品牌整合能力，期待通过深度协同，助力其突破地域边 界，成为世界级美妆企业。 公司方面向第一财经记者表示，此次融资的资金将用于进一步支持公司在产品研发、全球供应链、海外市场拓展及战略并购四大方向。公司正按照既定 战略节奏有序落地相关布局，未来会持续聚焦全球化、多品牌、高壁垒的发展路径。 记者注意到，随着中国美妆产业的成熟，本土企业在研发、生产、营销等领域的竞争力持续提升，叠加国内市场竞争日趋激烈，"出海"已成为众多本 土头部美妆企业寻求新增长的选择。 资本的助力成为本土美妆全球化 ...

Core Viewpoint - Yatsen E-commerce has made a significant move by issuing convertible bonds to attract strategic capital, marking a pivotal moment in its "second entrepreneurship" phase, especially after achieving its first annual positive Non-GAAP net profit and a skincare business that now constitutes over 60% of its revenue [2][5][6]. Group 1: Strategic Investment and Management Confidence - The participation of founder Huang Jinfeng in the bond subscription reflects management's strong confidence in the company's growth trajectory and commitment to a multi-brand strategy [3][5]. - The investment from CITIC Capital's private equity arm signifies institutional recognition of Yatsen E-commerce's strategic transformation and its potential to evolve into a global beauty group [3][6]. Group 2: Financial Structure and Long-term Growth - The issuance of convertible bonds aims to optimize Yatsen E-commerce's capital structure, providing necessary long-term capital while avoiding immediate dilution of existing shareholders' equity [5][6]. - As of December 31, 2025, the company holds cash and cash equivalents totaling 1.05 billion RMB, sufficient to support daily operations while enabling further investment in R&D and brand development [5]. Group 3: Business Transformation and Performance Metrics - Yatsen E-commerce has successfully transitioned from a makeup-centric business to a dual-driven model of skincare and makeup, with skincare revenue growing by 51.9% year-on-year in Q4 2025, now accounting for 61.1% of total revenue [9][10]. - The company's gross margin improved to 78.2% in 2025, driven by the structural shift towards higher-margin skincare products [6][9]. Group 4: R&D Investment and Future Prospects - The company has invested nearly 700 million RMB in R&D over the past four years, with R&D expenses consistently exceeding 3% of revenue, indicating a strong commitment to innovation [10][11]. - The partnership with CITIC Capital is expected to enhance Yatsen E-commerce's global R&D capabilities, facilitating the development of advanced products and accelerating its international expansion [15][17]. Group 5: Strategic Goals and Market Positioning - Yatsen E-commerce aims to narrate a new story focused on becoming a "world-class beauty innovation pioneer," leveraging its strong R&D and multi-brand strategy to shift from a cyclical to a value stock in the capital market [16][17]. - The company projects Q1 2026 revenue growth of 15% to 30%, indicating a positive outlook as it continues to refine its business model and expand its market presence [14][17].

Core Viewpoint - Yatsen E-commerce has made significant moves following its historic 2025 financial report, including a strategic capital raise through a convertible bond issuance, signaling strong confidence in its growth trajectory and a commitment to its multi-brand strategy [2][3]. Group 1: Strategic Capital Raise - The company announced a $120 million convertible bond issuance, with a 1.5% annual coupon rate and an initial conversion price set at $4.63 per ADS, representing a 20% premium over the average price prior to the agreement [2]. - The funds raised will primarily support product development, global supply chain integration, overseas market expansion, strategic acquisitions, and other corporate purposes [2]. - This capital raise is seen as a pivotal moment for Yatsen E-commerce, coinciding with its first annual positive Non-GAAP net profit and a significant increase in its skincare business [2][5]. Group 2: Management Confidence and Strategic Vision - Founder and CEO Huang Jinpeng's participation in the bond issuance reflects management's unwavering confidence in the company's long-term value and strategic execution [3]. - The partnership with CITIC Capital's Shincheng Capital is expected to enhance strategic collaboration and resource integration, aiming to transform Yatsen E-commerce from a "Chinese rising star" to a "global beauty group" [3][12]. Group 3: Financial Performance and Market Position - Yatsen E-commerce has achieved a gross margin of 78.2% in 2025, driven by a structural shift towards higher-margin skincare products, which now account for over 60% of total revenue [6][9]. - The company reported a revenue of 1.38 billion yuan in Q4 2025, marking a 20.1% year-on-year increase, demonstrating consistent growth over five consecutive quarters [9]. - The shift from a makeup-centric business model to a dual-driven approach of skincare and makeup has been successfully completed, with skincare revenue growing by 51.9% year-on-year [9][10]. Group 4: Research and Development Focus - Yatsen E-commerce has invested nearly 700 million yuan in R&D over the past four years, maintaining a R&D expense ratio above 3% [10][11]. - The company has filed 269 patents globally, including 84 invention patents, indicating a strong commitment to innovation [10]. - In Q4 2025, R&D investment grew by 47.2% year-on-year, significantly outpacing revenue growth, which is crucial for building a competitive edge in high-value skincare products [11]. Group 5: Future Growth and Global Expansion - The convertible bond issuance is strategically timed to support Yatsen E-commerce's goals for 2026, with projected revenue growth of 15% to 30% [13]. - The funds will enhance the global R&D framework, deepen supply chain integration, and facilitate strategic acquisitions, leveraging Shincheng Capital's expertise in cross-border mergers [13][14]. - The collaboration with Shincheng Capital is expected to accelerate Yatsen E-commerce's overseas expansion and provide comprehensive support for brand acquisition and market entry [14]. Conclusion - Yatsen E-commerce is poised to redefine its narrative in the capital market as a technology-driven multi-brand beauty group, with a focus on becoming a "world-class beauty innovation leader" [15].

Core Viewpoint - Yatsen Holding Limited has announced a private placement of convertible notes and warrants, raising approximately US$120 million to support its growth strategy and enhance its market position in the beauty industry [1]. Group 1: Investment Details - The investment involves RMB-denominated convertible senior notes issued in two equal tranches, with the first tranche expected in March 2026 and the second later in the year [1]. - The notes will bear an interest rate of 1.5% per annum, with an initial maturity of 364 days, extendable to five years upon receipt of a foreign debt registration certificate [1]. - The conversion price for the notes is set at $4.63, reflecting a 20% premium over the average price of the company's American depositary shares (ADSs) prior to the agreement [1]. Group 2: Use of Proceeds - The net proceeds from the issuance will be allocated towards product research and development, global supply chain integration, overseas market expansion, and strategic mergers and acquisitions [1]. - This funding aims to drive business growth and enhance the company's competitive position in the global beauty market [1]. Group 3: Strategic Partnerships - The investment highlights a strategic alliance with Trustar Capital, which will leverage its resources and expertise to assist Yatsen in capturing synergies across the beauty industry value chain [1]. - Trustar Capital's involvement is expected to support Yatsen's global expansion strategy and enhance its capabilities in cross-border mergers and acquisitions [1]. Group 4: Company Background - Yatsen Holding Limited, founded in 2016, is a leading beauty group in China, known for its innovative approach and a diverse portfolio of brands including Perfect Diary and DR.WU [2]. - The company aims to establish itself as a world-class pioneer in beauty innovation, focusing on product portfolio optimization and brand building [2].

Core Insights - Yatsen reported a return to growth and improved profitability in 2025, primarily driven by its skincare portfolio amid a competitive beauty market in China [3][6] - The company's skincare brands accounted for 61.1% of total net revenues in Q4 2025, with a significant 51.9% increase in skincare revenue [1][6] - The overall beauty industry in China showed resilience, with a reported 8.2% growth in beauty retail sales in Q4 2025, marking the highest quarterly growth rate of the year [2] Financial Performance - Q4 2025 total net revenues increased by 20.1% year over year to RMB 1.38 billion, up from RMB 1.15 billion in the prior year [1] - Full-year 2025 total net revenues rose by 26.7% to RMB 4.3 billion, driven by a 63.5% increase in skincare brand revenues [11] - Q4 net income was RMB 3.0 million compared to a loss in the previous year, while full-year net loss narrowed to RMB 92.4 million from RMB 710.2 million [6][13] Cost and Profitability Metrics - Selling and marketing expenses rose to 64.8% of revenue due to higher traffic acquisition costs, while total operating expenses decreased by 15.6% to RMB 1.08 billion [4][7] - Gross profit for Q4 increased by 20.0% to RMB 1.07 billion, with a gross margin of 77.7% [7] - The operating loss for Q4 narrowed to RMB 12.7 million from RMB 390.7 million a year earlier, with an operating loss margin improving to 0.9% [9][10] Liquidity and Cash Flow - Cash and short-term investments fell to RMB 1.05 billion as of December 31, 2025, down from RMB 1.36 billion a year earlier [4][17] - Net cash used in operating activities was RMB 69.4 million in Q4, compared to net cash generated of RMB 202.2 million in the prior-year period [17] Product Development and Brand Positioning - Yatsen's R&D efforts include proprietary ingredient development and AI utilization, with successful product launches such as the VB Serum and Couture Révélation Cellulaire Reviving Cream [15][16] - The DR.WU brand leveraged its clinical heritage to launch a PDRN serum, addressing the demand for at-home clinical results [16] Future Outlook - Management provided Q1 2026 revenue guidance of RMB 958.6 million to RMB 1.08 billion, expecting year-over-year growth of approximately 15% to 30% [19] - The company aims to improve net profit margins by focusing on skincare growth and benefiting from operating leverage as revenues increase [18]

Financial Data and Key Metrics Changes - Total net revenue for Q4 2025 increased by 20.1% to RMB 1.38 billion from RMB 1.15 billion in the prior year period, driven by a 51.9% increase in skincare brand revenues, despite a 9.1% decrease in color cosmetics revenues [11][12] - For the full year 2025, total net revenue increased by 26.7% to RMB 4.3 billion from RMB 3.39 billion, primarily due to a 63.5% increase in skincare brand revenues [18] - Gross profit for Q4 2025 increased by 20% to RMB 1.07 billion, with a gross margin of 77.7%, remaining largely flat compared to 77.8% in the prior year [11][12] - The company narrowed its full-year net loss margin to 2.2% from 20.9% in the prior year, with a net loss of RMB 92.4 million compared to RMB 710.2 million in the previous year [19][20] Business Line Data and Key Metrics Changes - Skincare brands accounted for 61.1% of total net revenues in Q4 2025, with DR.WU and Galénic being the primary growth drivers [5][6] - For the full year, skincare brands contributed 53% of total net revenues, while color cosmetics saw a slight increase of 1.9% year-over-year [6][18] Market Data and Key Metrics Changes - The beauty retail sales in China grew by 8.2% in Q4 2025, marking the highest quarterly growth rate of the year, and 5.1% for the full year, rebounding from a decline in 2024 [4] Company Strategy and Development Direction - The company is focused on three core initiatives: driving R&D-led product innovation, strengthening brand equities across its multi-brand portfolio, and improving overall profitability [6][10] - The R&D infrastructure has been leveraged to develop innovative products, with successful launches such as Galénic's VB Serum and Couture Révélation Cellulaire Reviving Cream [7][8] Management Comments on Operating Environment and Future Outlook - Management noted that while the beauty industry is recovering, competition has intensified, particularly during major shopping festivals [4] - The company expects total net revenues for Q1 2026 to be between RMB 958.6 million and RMB 1.08 billion, representing a year-over-year increase of approximately 15%-30% [23] Other Important Information - The company reported no impairment of goodwill for Q4 2025, contrasting with an impairment of RMB 403.1 million in the prior year [15] - Cash, restricted cash, and short-term investments as of December 31, 2025, were RMB 1.05 billion, down from RMB 1.36 billion a year earlier [22] Q&A Session Summary Question: Plans to improve net profit margin - Management indicated that the skincare business will continue to grow faster than color cosmetics, which typically have higher margins, thus improving the overall margin profile [26] Question: Plans to expand skincare brand portfolio - The focus will be on R&D to drive growth in the skincare business, which has seen significant top-line growth due to better products meeting consumer demand [27]

Financial Data and Key Metrics Changes - Total net revenue for Q4 2025 increased by 20.1% year-over-year to RMB 1.38 billion, driven by a 51.9% increase in skincare brand revenues, despite a 9.1% decrease in color cosmetics revenues [11][12] - For the full year 2025, total net revenue grew by 26.7% to RMB 4.3 billion, primarily due to a 63.5% increase in skincare brand revenues [18][19] - Gross profit for Q4 2025 rose by 20% to RMB 1.07 billion, with a gross margin of 77.7% [11][12] - The company narrowed its full-year net loss margin to 2.2% from 20.9% in the prior year, achieving a non-GAAP net income margin of 0.2% [19][21] Business Line Data and Key Metrics Changes - Skincare brands accounted for 61.1% of total net revenues in Q4 2025, with DR.WU and Galénic being the primary growth drivers [5][6] - For the full year, skincare brands contributed 53% of total net revenues, indicating a strong focus on this segment [6][18] - Color cosmetics revenues saw a slight increase of 1.9% year-over-year for the full year, contrasting with the significant growth in skincare [18] Market Data and Key Metrics Changes - The beauty retail sales in China grew by 8.2% in Q4 2025, marking the highest quarterly growth rate of the year, and 5.1% for the full year, indicating a recovery from the previous year's decline [4][5] Company Strategy and Development Direction - The company is committed to three core initiatives: driving R&D-led product innovation, strengthening brand equities across its multi-brand portfolio, and improving overall profitability [6][10] - The focus on R&D has led to successful product launches, such as Galénic's VB Serum and PDRN serum from DR.WU, which cater to evolving consumer demands [7][9] Management Comments on Operating Environment and Future Outlook - Management noted that while the beauty industry is recovering, competition remains intense, particularly during major shopping festivals [4][5] - The company expects total net revenues for Q1 2026 to be between RMB 958.6 million and RMB 1.08 billion, reflecting a year-over-year increase of approximately 15%-30% [23] Other Important Information - The company reported no impairment of goodwill for Q4 2025, contrasting with a significant impairment in the prior year [15] - Cash, restricted cash, and short-term investments as of December 31, 2025, were RMB 1.05 billion, down from RMB 1.36 billion a year earlier [22] Q&A Session Summary Question: Plans to improve net profit margin - Management indicated that the skincare business will continue to grow faster than color cosmetics, which typically have higher margins, thus improving the overall margin profile [26] Question: Plans to expand skincare brand portfolio - The focus will be on R&D to drive growth in the skincare business, leveraging past investments to meet consumer demand with better products [27]

Financial Data and Key Metrics Changes - Total net revenue for Q4 2025 increased by 20.1% year-over-year to RMB 1.38 billion, driven by a 51.9% increase in skincare brand revenues, despite a 9.1% decrease in color cosmetics revenues [11][12] - For the full year 2025, total net revenue rose by 26.7% to RMB 4.3 billion, primarily due to a 63.5% increase in skincare brand revenues [19][20] - Gross profit for Q4 2025 increased by 20% to RMB 1.07 billion, with a gross margin of 77.7% [11][12] - The company narrowed its full-year net loss margin to 2.2% from 20.9% in the prior year, achieving a non-GAAP net income margin of 0.2% [21] Business Line Data and Key Metrics Changes - Skincare brands accounted for 61.1% of total net revenues in Q4 2025, with DR.WU and Galénic being the primary growth drivers [5][6] - For the full year, skincare brands contributed 53% of total net revenues, indicating a strong focus on this segment [6] Market Data and Key Metrics Changes - China's beauty industry saw a retail sales growth of 8.2% in Q4 2025, with a full-year growth of 5.1%, marking a recovery from the previous year's decline [4] Company Strategy and Development Direction - The company is committed to three core initiatives: driving R&D-led product innovation, strengthening brand equities across its multi-brand portfolio, and improving overall profitability [6][10] - The focus on R&D has led to successful product launches, such as Galénic's VB Serum and PDRN serum from DR.WU, which cater to evolving consumer demands [7][9] Management's Comments on Operating Environment and Future Outlook - Management noted that while the market is recovering, competition remains intense, particularly during major shopping festivals [4] - The company expects total net revenues for Q1 2026 to be between RMB 958.6 million and RMB 1.08 billion, reflecting a year-over-year increase of approximately 15%-30% [24] Other Important Information - The company reported no impairment of goodwill for Q4 2025, contrasting with a significant impairment in the prior year [16] - Cash, restricted cash, and short-term investments as of December 31, 2025, were RMB 1.05 billion, down from RMB 1.36 billion a year earlier [22] Q&A Session Summary Question: Plans to improve net profit margin - Management indicated that the skincare business will continue to grow faster than color cosmetics, which typically have higher margins, thus improving the overall margin profile [27] Question: Plans to expand the skincare portfolio - The company emphasized that R&D will be crucial for the growth of its skincare business, highlighting past investments that have led to significant top-line growth [28]

Core Viewpoint - U.S. stock futures are experiencing a decline, particularly with Dow futures dropping approximately 1% on Monday, indicating a bearish sentiment in the market [1] Company Summary - Yatsen Holding Ltd – ADR (NYSE:YSG) reported a significant drop in adjusted earnings for the fourth quarter, with earnings per share decreasing to 7 cents from 14 cents in the same period last year [1] - The company's sales increased to $197.258 million, up from $157.347 million year-over-year, reflecting a positive growth in revenue despite the earnings decline [1] - In pre-market trading, Yatsen shares fell by 10.1%, reaching a price of $4.00 [1]